A detailed history of Siren, L.L.C. transactions in Regenxbio Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 284,000 shares of RGNX stock, worth $3.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
284,000
Holding current value
$3.03 Million
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.49 - $14.39 $2.98 Million - $4.09 Million
284,000 New
284,000 $2.98 Billion

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $461M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Siren, L.L.C. Portfolio

Follow Siren, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siren, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Siren, L.L.C. with notifications on news.